trending Market Intelligence /marketintelligence/en/news-insights/trending/mthrIQhtp1m9Kwa5rJwt2g2 content esgSubNav
In This List

Grifols sells 2 businesses to shareholder Scranton Enterprises for $537M

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Grifols sells 2 businesses to shareholder Scranton Enterprises for $537M

Spanish biotechnology company Grifols SA said it sold two businesses it acquired earlier this year to its existing shareholder Scranton Enterprises BV.

Scranton will pay $537 million for the businesses, effectively the same price Grifols paid when it acquired Haema AG for €220 million in June and Biotest US Corp. for $286 million in August.

Biotest and Haema will continue to provide plasma to Grifols under a supply agreement that has been extended to a 30-year period. Grifols also has the ability to repurchase the businesses.